Articles related to PHARMACY OPERATIONS & MGMT

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.

This case exemplifies the dire consequences of unethical practices in the health care and pharmaceutical industries, emphasizing the need for physicians to remain vigilant and uphold the highest ethical standards in patient care and medication prescribing.

The ASHP’s newly revised guidelines offer actionable steps for community pharmacies to combat controlled substance diversion, addressing both patient safety and regulatory compliance.

Prescription digital therapeutics (PDTs) are a rapidly growing area of healthcare. As a pharmacist, you should be aware of the potential benefits and risks of PDTs for your patients.

Explore the DEA’s latest regulations on electronic prescriptions for controlled substances, a significant step towards modernizing pharmacy practices. Learn more about how these changes may impact the way prescriptions are transferred and managed, aligning with current technological advancements and legal requirements.